n Cardiovascular Journal of South Africa - COMET challenges paradigm of ACE inhibition in mild heart failure : drug trends in cardiology
|Article Title||COMET challenges paradigm of ACE inhibition in mild heart failure : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||Jul 2003|
|Pages||207 - 208|
Extracted from text ... COMET challenges paradigm of ACE inhibition in mild heart failure 'The results of the COMET study in chronic heart failure show the clear survival benefits of carvedilol (Dilatrend(r)) to a level far greater than anyone had anticipated', noted Prof. P. Poole- Wilson, Chairman of the Steering Committee of the COMET Study at the recent presentation of final results in Strasbourg. South African primary-care physicians were also recently given the opportunity to view these results via video during a satellite CME on heart failure treatment presented by leading South African specialists with sponsorship from Roche Pharmaceuticals. Focusing firstly on the remodelling ..
Article metrics loading...